C. Andersson

发表

Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia.

Claes R. Andersson, M. Höglund, A. Österroos, 2016, Biochemical pharmacology.

Sorafenib and nitazoxanide disrupt mitochondrial function and inhibit regrowth capacity in three-dimensional models of hepatocellular and colorectal carcinoma

Claes R. Andersson, C. Bréchot, M. Jarvius, 2022, Scientific Reports.

The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation

Claes R. Andersson, M. Jarvius, K. Blom, 2017, Immunopharmacology and immunotoxicology.

Melphalan flufenamide inhibits osteoclastogenesis by suppressing proliferation of monocytes

Claes R. Andersson, H. Melhus, A. Slipicevic, 2021, Bone reports.

Single-cell transcriptional pharmacodynamics of trifluridine in a tumor-immune model

Claes R. Andersson, M. Jarvius, C. Andersson, 2022, Scientific Reports.

Assessment in vitro of interactions between anti-cancer drugs and noncancer drugs commonly used by cancer patients

Claes R. Andersson, K. Blom, C. Andersson, 2022, Anti-cancer drugs.

Targeting tumor cells based on Phosphodiesterase 3A expression

Claes R. Andersson, M. Nazir, M. Jarvius, 2017, Experimental cell research.

Prediction of drug class and adverse side effects based on induced gene expression profiles - a feasability study

Claes Andersson, Mats G. Gustafsson, Claes R. Andersson, 2012 .

Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death

Claes R. Andersson, M. Jarvius, C. Andersson, 2023, BMC Cancer.

Mebendazole is unique among tubulin-active drugs in activating the MEK–ERK pathway

Claes R. Andersson, M. Jarvius, K. Blom, 2020, Scientific Reports.

Synergistic interactions between camptothecin and EGFR or RAC1 inhibitors and between imatinib and Notch signaling or RAC1 inhibitors in glioblastoma cell lines

Claes R. Andersson, A. Isaksson, M. Bergqvist, 2013, Cancer Chemotherapy and Pharmacology.

Predictive Value of Ex Vivo Chemosensitivity Assays for Individualized Cancer Chemotherapy: A Meta-Analysis

K. Blom, C. Andersson, R. Larsson, 2017, SLAS technology.

Screening for phenotype selective activity in multidrug resistant cells identifies a novel tubulin active agent insensitive to common forms of cancer drug resistance

Claes R. Andersson, G. Westman, S. Linder, 2013, BMC Cancer.

Fusing Domain Knowledge with Data : Applications in Bioinformatics

Claes Andersson, Claes R. Andersson, C. Andersson, 2008 .

A strand specific high resolution normalization method for chip-sequencing data employing multiple experimental control measurements

Robin Andersson, Jan Komorowski, Claes R Andersson, 2012, Algorithms for Molecular Biology.

Multiplexed Homogeneous Proximity Ligation Assays for High-throughput Protein Biomarker Research in Serological Material*

Claes R. Andersson, J. Stenvang, H. Nielsen, 2011, Molecular & Cellular Proteomics.

Revealing cell cycle control by combining model-based detection of periodic expression with novel cis-regulatory descriptors

Jan Komorowski, Torgeir R. Hvidsten, Mats G. Gustafsson, 2007, BMC Systems Biology.

A high resolution normalization strategy of chip-sequencing data using (multiple) experimental control measurements

Jan Komorowski, Robin Andersson, Mats Gustavsson, 2010 .

Brunn: An open source laboratory information system for microplates with a graphical plate layout design process

Ola Spjuth, Jonathan Alvarsson, Jarl E. S. Wikberg, 2011, BMC Bioinformatics.

In vitro discovery of promising anti-cancer drug combinations using iterative maximisation of a therapeutic index

Claes R. Andersson, M. Kashif, C. Andersson, 2015, Scientific Reports.

Self-tuning density estimation based on Bayesian averaging of adaptive kernel density estimations yields state-of-the-art performance

Mats G. Gustafsson, Claes R. Andersson, Christofer L. Bäcklin, 2018, Pattern Recognit..

A Pragmatic Definition of Therapeutic Synergy Suitable for Clinically Relevant In Vitro Multicompound Analyses

Ulf Hammerling, Magnus Åberg, Muhammad Kashif, 2014, Molecular Cancer Therapeutics.

Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition

M. Jarvius, K. Blom, C. Andersson, 2019, BMC Research Notes.

Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition

M. Jarvius, K. Blom, C. Andersson, 2019, BMC Research Notes.

Large-scale ligand-based predictive modelling using support vector machines

Ola Spjuth, Jonathan Alvarsson, Jarl E. S. Wikberg, 2016, Journal of Cheminformatics.

Benchmarking Study of Parameter Variation When Using Signature Fingerprints Together with Support Vector Machines

Ola Spjuth, Lars Carlsson, Jonathan Alvarsson, 2014, J. Chem. Inf. Model..

Ex Vivo Assessment of Drug Activity in Patient Tumor Cells as a Basis for Tailored Cancer Therapy

Jonathan Alvarsson, Rolf Larsson, Claes R. Andersson, 2016, Journal of laboratory automation.

Ex vivo assessment of chemotherapy sensitivity of colorectal cancer peritoneal metastases.

K. Blom, C. Andersson, P. Nygren, 2023, The British journal of surgery.

In Vitro Drug Sensitivity-Gene Expression Correlations Involve a Tissue of Origin Dependency

Mårten Fryknäs, Rolf Larsson, Mats G. Gustafsson, 2007, J. Chem. Inf. Model..